Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.2 Research Methodology
1.2.1 Information Procurement
1.3 Information or Data Analysis
1.4 Market Formulation & Validation
1.4.1 Australia Legal Cannabis Market: CAGR Calculation
1.5 List Of Secondary Sources
1.6 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot, Revenue (USD Million)
Chapter 3 Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping
3.2 Australia Legal Cannabis Market Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Rising patient population
3.2.1.2 Increasing legalization of cannabis
3.2.1.3 Entry of international players
3.2.2 Market Restraints Analysis
3.2.2.1 Stringent regulations on hemp usage
3.2.2.2 Increasing illicit cannabsi trade
3.2.3 Industry Challenge
3.3 Regulatory Framework
3.3.1 Australia
3.3.1.1 Cultivation/Production
3.3.1.2 Legal Status of Cannabis Derived Products
3.3.1.3 Regulatory Bodies Involved
3.3.1.4 Import/Export Scenario
3.4 Australia Legal Cannabis Market Market Analysis Tools
3.4.1 Australia Legal Cannabis Market Market - PESTLE Analysis
3.4.2 Industry Analysis - Porter’s
3.5 Opportunity Analysis (2016-2019-2026)
3.6 Value Chain Analysis
3.6.1 Raw Materials Trends
3.6.1.1 Market price evolution of biomass commodity cost (to processor)
3.6.2 Manufacturing Trends
3.7 Medical Cannabis Users Pool Analysis, 2016 - 2026
Chapter 4 Australia Legal Cannabis Market Market: Product Type Market Estimates & Trend Analysis
4.1 Australia Legal Cannabis Market Market: Product Type Analysis
4.1.1. Marijuana
4.1.1.1 Marijuana market, 2016 - 2026 (USD Million)
4.1.1.2 Flower
4.1.1.2.1 Flower market, 2016 - 2026 (USD Million)
4.1.1.3 Oil
4.1.1.3.1 Oil market, 2016 - 2026 (USD Million)
4.1.2 Hemp oil
4.1.2.1 Hemp oil market, 2016 - 2026 (USD Million)
Chapter 5 Australia Legal Cannabis Market Market: Application Type Market Estimates & Trend Analysis
5.1 Australia Legal Cannabis Market Market: Application Type Analysis
5.1.1. Adult use
5.1.1.1 Adult use market, 2016 - 2026 (USD Million)
5.1.2 Medical
5.1.2.1 Medical use market, 2016 - 2026 (USD Million)
5.1.2.2 Chronic Pain
5.1.2.2.1 Chronic pain market, 2016 - 2026 (USD Million)
5.1.2.3 Anxiety
5.1.2.3.1 Australiaanxietymarket, 2016 - 2026 (USD Million)
5.1.2.4 Inflammation
5.1.2.4.1 Inflammation market, 2016 - 2026 (USD Million)
5.1.2.5 Sleep Disorder
5.1.2.5.1 Sleep Disordermarket, 2016 - 2026 (USD Million)
5.1.2.6 Others
5.1.2.6.1 Other applicationmarket, 2016 - 2026 (USD Million)
5.1.3 B2B Channel
5.1.3.1 B2B channel market, 2016 - 2026 (USD Million)
Chapter 6 Competitive Landscape
6.1 COMPANY PROFILES
6.1.1 AusCann Group Holdings Pty Ltd
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 Cann Group Ltd
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic Initiatives
6.1.3 Bod Australia
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Product benchmarking
6.1.3.4 Strategic initiatives
6.1.4 Zelira Therapeutics
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Product benchmarking
6.1.4.4 Strategic Initiatives
6.1.5 Althea Group Holdings Limited
6.1.5.1 Company overview
6.1.5.2 Product benchmarking
6.1.5.3 Product benchmarking
6.1.5.3 Strategic Initiatives
6.1.6 THC Global Group Limited
6.1.6.1 Company overview
6.1.6.2 Financial performance
6.1.6.3 Product benchmarking
6.1.6.4 Strategic Initiatives
6.1.7 MGC Pharmaceuticals Ltd
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Product benchmarking
6.1.7.4 Strategic Initiatives
6.1.8 Ecofibre Limited
6.1.8.1 Company overview
6.1.8.2 Financial performance
6.1.8.3 Product benchmarking
6.1.8.4 Strategic Initiatives



List of Tables


List of Tables



Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 3 Australia Medical Cannabis User Pool Analysis, 2016 - 2026